ACTH 1-24 and other melanocortins for COVID-19 treatment

Affiliations

¹ Department of Medicine and Division of Clinical Pharmacology, School of Medicine , UNIMORE, Policlinico via del Pozzo 71, 41124 Modena, Italy.
² GVM Care and Research Maria Cecilia Hospital, Cardiac Surgery Unit, via Corriera 1, 48033 Cotignola (Ra), Italy.

Comment

Alfio Bertolini et al. Shock. 2020 Nov.

. 2020 Nov;54(5):701-702.

doi: 10.1097/SHK.0000000000001604.

¹ Department of Medicine and Division of Clinical Pharmacology, School of Medicine , UNIMORE, Policlinico via del Pozzo 71, 41124 Modena, Italy.
² GVM Care and Research Maria Cecilia Hospital, Cardiac Surgery Unit, via Corriera 1, 48033 Cotignola (Ra), Italy.

No abstract available

Comment on

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed.
Feldmann M, Maini RN, Woody JN, Holgate ST, Winter G, Rowland M, Richards D, Hussell T. Feldmann M, et al. Lancet. 2020 May 2;395(10234):1407-1409. doi: 10.1016/S0140-6736(20)30858-8. Epub 2020 Apr 9. Lancet. 2020. PMID: 32278362 Free PMC article. No abstract available.

1. Feldmann M, Maini EN, Woody JN, Holgate ST, Winter G, Rowland M, Richards D, Hussell T. Trials of anti-tumor necrosis factor therapy for COVID-19 are urgently needed. Lancet 395 (10234):1407–1409, 2020.
1. Bertolini A, Guarini S, Ferrari W. Adrenal-independent, anti-shock effect of ACTH-(1-24) in rats. Eur J Pharmacol 122:387–388, 1986.
1. Bertolini A, Ferrari W, Guarini S. The adrenocorticotropic hormone (ACTH)-induced reversal of hemorrhagic shock. Resuscitation 18:253–269, 1989.
1. Guarini S, Bazzani C, Bertolini A. Resuscitating effect of melanocortin peptides after prolonged respiratory arrest. Br J Pharmacol 121:1454–1460, 1997.
1. Altavilla D, Cainazzo MM, Squadrito F, Guarini S, Bertolini A, Bazzani C. Tumour necrosis factor-alpha as a target of melanocortins in haemorrhagic shock, in the anesthetized rat. Br J Pharmacol 124:1587–1590, 1998.